Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome: the dal-GenE trial

Tardif, JC; Pfeffer, MA; Kouz, S; Koenig, W; Maggioni, AP; McMurray, JJV; Mooser, V; Waters, DD; Gregoire, JC; L'Allier, PL; Jukema, JW; White, HD; Heinonen, T; Black, DM; Laghrissi-Thode, F; Levesque, S; Guertin, MC; Dube, MP; Investigators, DG

Tardif, JC (通讯作者)，Univ Montreal, Montreal Heart Inst, Dept Med, 5000 Belanger St, Montreal, PQ H1T 1C8, Canada.;Tardif, JC (通讯作者)，Univ Montreal, Beaulieu Saucier Pharmacogen Ctr, Montreal, PQ, Canada.;Tardif, JC (通讯作者)，Montreal Hlth Innovat Coordinating Ctr MHICC, Montreal, PQ, Canada.

EUROPEAN HEART JOURNAL, 2022; 43 (39): 3947

Abstract

Aims In a retrospective analysis of dal-Outcomes, the effect of dalcetrapib on cardiovascular events was influenced by an adenylate cyclase type 9 (AD......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索